![](/img/cover-not-exists.png)
A Phase I Study of Bexarotene, a Retinoic X Receptor Agonist, in Non-M3 Acute Myeloid Leukemia
Tsai, D. E., Luger, S. M., Andreadis, C., Vogl, D. T., Kemner, A., Potuzak, M., Goradia, A., Loren, A. W., Perl, A. E., Schuster, S. J., Porter, D. L., Stadtmauer, E. A., Goldstein, S. C., Thompson, JVolume:
14
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-07-5185
Date:
September, 2008
File:
PDF, 299 KB
english, 2008